In people with type 2 diabetes in the world's richest countries, deaths from cardiovascular disease are declining while ...

A large study found that people taking GLP-1 drugs like Ozempic for diabetes were less likely to be diagnosed with substance use disorder.

A new study suggests GLP-1 drugs like Ozempic and Wegovy may raise fracture risk by 11% in adults 65 and older with Type 2 diabetes compared to other diabetes medications.

A new study reports that GLP-1 semaglutide medications may help reverse the effects of osteoarthritis in the joints by ...

Al-Aly and his colleagues found that people starting the GLP-1 drugs had lower risks of developing addiction to multiple ...

A large epidemiological study of more than 600,000 veterans with diabetes suggests GLP-1 weight-loss medications may reduce ...

Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed ...

The search for long COVID treatments continues, as a randomized clinical trial found that a two-week course of metformin or ursodeoxycholic acid (UDCA) did not meaningfully improve recovery from ...

Researchers from Queen Mary University of London have found that a medication originally developed for glycemic control can reverse serious heart damage—not by controlling blood sugar as originally ...

A growing body of research suggests the brain plays a central role in diabetic ketoacidosis, opening the possibility of treating type 1 diabetes in an entirely new way.

An “immune system reset” eliminated autoimmune, or Type 1, diabetes in mice in a study conducted at. Researchers say the strategy could also have potential for treating other autoimmune diseases and ...

Norton Healthcare is opening a new islet cell lab to treat chronic pancreatitis and research a cure for Type 1 diabetes. The first phase will treat pancreatitis by transplanting a patient's own islet ...